Testosterone prior to hypospadias repair : Postoperative complication rates and long-term cosmetic results, penile length and body height

Introduction: The use of hormonal therapy was first described in 1971 before hypospadias surgery, and it has been debated ever since. The long-term outcomes after puberty of patients treated with pre-operative testosterone in childhood are lacking. Objectives: Possible long-term effects of testosterone are often asked about in daily practice. The current study investigated the long-term outcomes regarding height, penile length and penile cosmesis in adult men after hypospadias surgery in childhood with and without pre-operative testosterone. Methods: Adult men (n = 121) who underwent primary hypospadias repair in childhood were included. Pre-operative penile appearance, judged by a paediatric urologist, determined the use of pre-operative testosterone. Data on hypospadias characteristics, healing complications, surgical repair, and testosterone use were collected retrospectively. At adult age, stretched penile length and body height were measured, and penile cosmesis was evaluated using the Pediatric Penile Perception Score (PPPS). Results: Postoperative complication rates in patients (n = 121) with and without testosterone were similar (50% vs. 43%; P = 0.54). Sixty adult patients (50%) with a median age of 19.8 years and follow-up time of 18.3 years were examined at the outpatient clinic at adult age. Of this group, testosterone was applied in 12/43 patients with distal, 3/6 patients with midshaft, and 9/11 patients with proximal hypospadias. Adult stretched penile length (12.0 cm vs. 12.4 cm; P = 0.47) and adult height (180.1 cm vs. 179.0 cm P = 0.65) showed no difference between patients with and without testosterone treatment. Penile cosmesis was (very) satisfactory in all PPPS domains, and showed no difference between the testosterone group and the non-testosterone group. Univariate and multivariate analysis was conducted to determine if the hypospadias type or pre-operative testosterone therapy had more influence on the long-term outcomes. None of the long-term outcomes were significantly associated with pre-operative testosterone therapy on multivariate analysis. Discussion: This was the first study reporting long-term outcomes of hypospadias patients after puberty who received pre-operative hormonal therapy. Validated instruments were used as much as possible. Shortcomings of this study were the 50% response rate, the retrospective design, and the lack of objective inclusion criteria reported to indicate pre-operative testosterone therapy. Conclusion: This study suggested that the long-term results of patients receiving pre-operative testosterone treatment, who often had more challenging hypospadias, were similar to those who did not. However, a randomised controlled study is needed to confirm these results. [Table presented

De FUTURE trial; een multicenter RCT naar MRI-geleide prostaatbiopten : Vergelijking van drie technieken van target biopten en vergelijking met systematische biopten

The FUTURE trial is a multicenter RCT on 3 MRI-based target biopsy (TB) techniques among patients with negative systematic biopsies (SBs) and persisting suspicion of prostate cancer. Between 2014 and 2017 665 patients underwent multiparametric MRI. 234 (35%) patients with a PIRADS ≥3 lesion were randomised 1:1:1 for TB: in-bore MRI (MRI-TB), MRI/ultrasound fusion (FUS-TB), and cognitive fusion (COG-TB). After FUS-TB and COG-TB additional SB was performed. No significant differences in prostate cancer detection and significant prostate cancer were found (MRI-TB 54.5%/32.5%, FUS-TB 49.4%/34.2%, and COG-TB 43.6%/33.3%, p = 0.39/p = 0.98). Combined SBs and TBs versus TBs alone resulted in 1% more csPCa detection (35% vs 34%). There was no significant advantage of one TB technique for the detection of overall prostate cancer, nor for clinically significant prostate cancer. The additional value of SBs was limited